K191083 is an FDA 510(k) clearance for the COMPLETE CONTROL System Gen2. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.
Submitted by Coapt, LLC (Chicago, US). The FDA issued a Cleared decision on May 24, 2019 after a review of 30 days — a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 — the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.